Research Links Coffee Consumption to Longer Life
Consuming more than three cups of coffee per day can decrease the risk of “all- cause mortality,” according to recent research from South Korea published in the Journal of the Academy of Nutrition and Dietetics.
The researchers were examining the association between coffee consumption and all-cause mortality and cause-specific mortality risks in the Korean population.
In total, 173,209 participants aged 40 years and older from the study were enrolled between 2004 and 2013.
But the researchers were particularly interested in the impact of coffee consumption on the 110,920 participants without cancer, cardiovascular disease or diabetes and how it impacted their mortality through Dec. 31, 2018.
What they found is that compared with non-consumers of coffee, participants who consumed more than three cups per day had a reduced risk of all-cause mortality. Participants who consumed one or up to three cups a day had a reduced risk of cardiovascular disease-related mortality.
The reseachers said the study provides evidence that greater coffee consumption is associated with a decreased risk of all-cause mortality and even moderate coffee consumption is associated with a decreased risk of cardiovascular disease mortality — and this held true regardless of the type of coffee.
The researchers included Seong-Ah Kim, Ph.D., a research fellow at The Seoul Institute; Li-Juan Tan, a graduate student in the Department of Food and Nutrition at Chung-Ang University; and Sangah Shin, Ph.D., a professor in the Department of Food and Nutrition at Chung-Ang University.
In The News
Health
Voting
Research
WASHINGTON - The Library of Congress has acquired a digital archive of the real-time impressions of more than 200 frontline health care workers documenting the country in crisis during the coronavirus pandemic. The audio diaries from health care workers were collected by The Nocturnists, a medical storytelling... Read More
SILVER SPRING, Md. — The Food and Drug Administration on Monday granted its approval to aducanumab, an Alzheimer’s treatment developed by Biogen for use in patients, despite mixed clinical trial results for the drug. Prescribed under the brand name “Aduhelm,” the treatment is given intravenously and... Read More
A quartet of researchers in the United Kingdom say while the COVID-19 pandemic forced employers and employees alike into a “mass experiment” of workplace adjustments, the real work on what the future of work will look like is only just beginning. The researchers are Oliver Mallett,... Read More
A group of Harvard researchers has come out against the U.S. Census Bureau's use of a controversial method to protect privacy with the numbers used for redrawing congressional and legislative districts, saying it doesn't produce data good enough for redistricting. The Harvard researchers said in a... Read More
A healthy diet around the time of conception through the second trimester may reduce the risk of several common pregnancy complications, according to a new study from the National Institutes of Health. Expectant women in the study who scored high on any of three measures of... Read More
A new study by researchers at the National Institutes of Health and their colleagues has found that SARS-CoV-2, the virus that causes COVID-19, does not appear to pose a threat to the safety of the nation’s blood supply. The analysis, published in Transfusion, supports current donor... Read More
